Wilhelmus Groenhuysen

2018

In 2018, Wilhelmus Groenhuysen earned a total compensation of $3.5M as Chief Financial Officer at NovoCure, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$375,375
Option Awards$1,966,162
Salary$600,600
Stock Awards$489,580
Other$27,500
Total$3,459,217

Groenhuysen received $2M in option awards, accounting for 57% of the total pay in 2018.

Groenhuysen also received $375.4K in non-equity incentive plan, $600.6K in salary, $489.6K in stock awards and $27.5K in other compensation.

Rankings

In 2018, Wilhelmus Groenhuysen's compensation ranked 3,297th out of 14,244 executives tracked by ExecPay. In other words, Groenhuysen earned more than 76.9% of executives.

ClassificationRankingPercentile
All
3,297
out of 14,244
77th
Division
Manufacturing
1,218
out of 5,759
79th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
148
out of 849
83rd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
77
out of 547
86th
Industry
Surgical and Medical Instruments and Apparatus
48
out of 348
86th
Source: SEC filing on April 10, 2019.

Groenhuysen's colleagues

We found five more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2018.

2018

Asaf Danziger

NovoCure

Chief Executive Officer

2018

William Doyle

NovoCure

Chairman

2018

Eilon Kirson

NovoCure

Chief Scientific Officer

2018

Pritesh Shah

NovoCure

Chief Commercial Officer

2018

Michael Ambrogi

NovoCure

Chief Operating Officer

News

In-depth

You may also like